Data / Federal awards / NAICS 541714 / MAPP BIOPHARMACEUTICAL, INC.
MAPP BIOPHARMACEUTICAL, INC.: 14 federal contract awards, $134.2 million obligated (FY2024 to FY2027)
Updated October 6, 2026. Source: USAspending.gov.
MAPP BIOPHARMACEUTICAL, INC. (UEI M9V9QTHR1H28), San Diego, CA, received 14 federal prime contract awards with $134.2 million obligated in fiscal years 2024 to 2027, from 2 agencies under 6 NAICS codes. Its largest buyer is Department of Health and Human Services ($134.1 million) and its largest code is NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The request: Every federal contract awarded under NAICS 541714, with the winner, the agency and the value. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- M9V9QTHR1H28UEI
- San Diego, CALocation
- Small BusinessBusiness size
- 14Contract awards
- $134.2 millionObligated
- 2023-11-03First action in window
- 2026-09-30Latest action
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | 5 | $136.1 million |
| 325413 | In-Vitro Diagnostic Substance Manufacturing | 5 | $201,750 |
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 1 | $0 |
| 541711 | Research and Development in Biotechnology | 1 | $0 |
| 541380 | Testing Laboratories and Services | 1 | $-99,275 |
| 541720 | Research and Development in the Social Sciences and Humanities | 1 | $-2,050,557 |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Health and Human Services | 8 | $134.1 million |
| Department of Defense | 6 | $102,475 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $3 million |
| FY2025 | $48.1 million |
| FY2026 | $83.1 million |
Contract awards
All 14 awards in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 75A50122C00061 | Department of Health and Human Services | Definitive Contract | 541714 | PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES | $86,076,373 | $220,916,162 | September 30, 2022 | September 30, 2030 | San Diego, CA | usaspending.gov |
| 75A50122C00076 | Department of Health and Human Services | Definitive Contract | 541714 | THIS COST-PLUS-FIXED-FEE CONTRACT WITH MAPP BIOPHARMACEUTICAL, INC. (MAPP OR CONTRACTOR) IS FOR THE DEVELOPMENT OF MAPP?S THERAPEUTIC INTERV | $44,335,303 | $155,212,688 | September 28, 2022 | December 31, 2032 | San Diego, CA | usaspending.gov |
| 75A50124C00003 | Department of Health and Human Services | Definitive Contract | 541714 | DEVELOPMENT OF MEDICAL COUNTERMEASURES THROUGH PLANNED CLINICAL TRIALS AND OUTBREAK PREPAREDNESS | $5,626,972 | $5,626,972 | March 20, 2024 | December 31, 2032 | San Diego, CA | usaspending.gov |
| HT942525F0237 | Department of Defense | Delivery Order | 325413 | ANTIBODY & ANTIGEN SUPPLY | $110,500 | $110,500 | June 6, 2025 | December 4, 2025 | San Diego, CA | usaspending.gov |
| 75A50120C00198 | Department of Health and Human Services | Definitive Contract | 541714 | DEVELOPMENT OF A PAN-BOTULINUM NEUROTOXIN MEDICAL COUNTERMEASURE | $109,456 | $16,413,163 | September 30, 2020 | June 30, 2026 | San Diego, CA | usaspending.gov |
| HT942525FE048 | Department of Defense | Delivery Order | 325413 | HUMAN-DERIVED MONOCLONAL ANTIBODIES AND RECOMBINANT ANTIGENS | $60,500 | $60,500 | September 19, 2025 | February 25, 2026 | San Diego, CA | usaspending.gov |
| HT942626FE011 | Department of Defense | Delivery Order | 325413 | PROCUREMENT OF HUMAN DERIVED MONOCLONAL ANTIBODIES AND ANTIGENS | $20,500 | $20,500 | February 6, 2026 | April 24, 2026 | San Diego, CA | usaspending.gov |
| HT942626FE075 | Department of Defense | Delivery Order | 325413 | PROCUREMENT OF HUMAN DERIVED MONOCLONAL ANTIBODIES AND RECOMBINANT ANTIGENS | $10,250 | $10,250 | July 2, 2026 | October 1, 2026 | San Diego, CA | usaspending.gov |
| 75A50119D00018 | Department of Health and Human Services | IDC | 541714 | MAPP 2019 CONTRACT | $0 | $50,097,495 | June 3, 2019 | usaspending.gov | ||
| 75A50118C00024 | Department of Health and Human Services | Definitive Contract | 541715 | IGF::OT::IGF | $0 | $56,704,950 | September 25, 2018 | December 31, 2024 | San Diego, CA | usaspending.gov |
| HHSO100201700023C | Department of Health and Human Services | Definitive Contract | 541711 | IGF::OT::IGF | $0 | $7,486,451 | September 13, 2017 | June 30, 2022 | San Diego, CA | usaspending.gov |
| HT942525D0009 | Department of Defense | IDC | 325413 | MATERIAL REQUIREMENT FOR THE DELIVERY OF ANTIBODY AND ANTIGEN SUPPLY. | $0 | $2,000,000 | June 1, 2025 | usaspending.gov | ||
| W81XWH21C0121 | Department of Defense | Definitive Contract | 541380 | BASE YEAR FOR MACV CONTRACT GENERATES MACV IGG2 | $-99,275 | $767,803 | September 30, 2021 | March 1, 2024 | Frederick, MD | usaspending.gov |
| HHSO100201600021C | Department of Health and Human Services | Definitive Contract | 541720 | MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONSEXPANDED ACCESS PROTOCOL FOR ZMAPP | $-2,050,557 | $28,870,288 | June 27, 2016 | December 31, 2026 | San Diego, CA | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- All recipients under NAICS 325413 In-Vitro Diagnostic Substance Manufacturing
- All recipients under NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Open opportunities under NAICS 541714
- Open opportunities under NAICS 325413
- Open opportunities under NAICS 541715
Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.